Copertina

Venetoclax‐based non‐intensive combinations for relapsed/refractory acute myeloid leukaemia—Real‐world data from a UK ‐wide programme

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Henry Wood, Jenny O'Nions, Wei Yee Chan, Albert Borg, Scott Veitch, Patrick Elder, Manish Jain, James Aries, Steven Leak, Emily Mitchell, Jiri Pavlu, Jad Othman, Richard Dillon, Priyanka Mehta, Vidhya Murthy, Steven Knapper, Victoria Potter, Mhairi Copland, Charles Craddock, Pramila Krishnamurthy
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	British Journal of Haematology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Extramedullary chronic phase chronic myeloid leukaemia (CML) involving the central nervous system: A case report
di: Akshay Deshpande, et al.
Pubblicazione: (2024)

Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study
di: Yiling Ye, et al.
Pubblicazione: (2025)

Venetoclax plus hypomethylating agents as effective bridge therapy to allogeneic stem cell transplant in relapsed/refractory acute myeloid leukaemia: A subanalysis of the AVALON study
di: Elisabetta Petracci, et al.
Pubblicazione: (2025)

Neodymium isotope data for manganese nodules, crusts and sediments
di: Goldstein, Steven L, et al.
Pubblicazione: (2022)

Strontium isotope data for manganese nodules, crusts and sediments from the ocean
di: Goldstein, Steven L, et al.
Pubblicazione: (2022)

Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia
di: Francesca A. M. Kinsella, et al.
Pubblicazione: (2024)

Venetoclax resistance in acute myeloid leukaemia—Clinical and biological insights
di: Boaz Nachmias, et al.
Pubblicazione: (2024)

CAR‐DC combined with CAR‐T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives
di: Rui Zhang, et al.
Pubblicazione: (2025)

Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
di: Peiqi Liang, et al.
Pubblicazione: (2024)

Introducing a prognostic score for successful treatment‐free remission in chronic myeloid leukaemia
di: Simone Claudiani, et al.
Pubblicazione: (2026)

Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia
di: Tony Marchand, et al.
Pubblicazione: (2024)

Prognostic impact of valemetostat in relapsed/refractory adult T‐cell leukaemia‐lymphoma
di: Takafumi Shichijo, et al.
Pubblicazione: (2025)

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation
di: Francesca Perutelli, et al.
Pubblicazione: (2025)

(Table 3) Rare earth element contents of basalts from DSDP Leg 37
di: O'Nions, R K, et al.
Pubblicazione: (1976)

Strontium isotope and rare earth element geochemistry of basalts from DSDP Leg 37
di: O'Nions, R K, et al.
Pubblicazione: (2008)

(Table 1) 87Sr/86Sr ratios of basalts from DSDP Leg 37
di: O'Nions, R K, et al.
Pubblicazione: (1976)

(Appendix) Sample description of DSDP Leg 37
di: O'Nions, R K, et al.
Pubblicazione: (1976)

(Table 2) 87Sr/86Sr ratios of leaching experiments with basalts from DSDP Leg 37
di: O'Nions, R K, et al.
Pubblicazione: (1976)

Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)—An open‐label, phase I/II study
di: Ivetta Danylesko, et al.
Pubblicazione: (2025)

High throughput screening aids clinical decision‐making in refractory acute myeloid leukaemia
di: S. J. Jessop, et al.
Pubblicazione: (2024)

Two new options for NPM1 ‐mutated relapsed, refractory acute myeloid leukemia
di: Leah Lawrence
Pubblicazione: (2026)

Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post‐revumenib therapies
di: Miles Thomas, et al.
Pubblicazione: (2025)

Minor-element chemical analyses of Hole 37-332B
di: O'Nions, R K, et al.
Pubblicazione: (2005)

Minor-element chemical analyses of Hole 37-335
di: O'Nions, R K, et al.
Pubblicazione: (2005)

Droplet digital PCR for sensitive relapse detection in acute myeloid leukaemia patients transplanted by reduced intensity conditioning
di: Jonas Kassow Gronlund, et al.
Pubblicazione: (2024)

Hypomethylating agent and venetoclax are effective salvage therapies in relapsed/refractory early T‐cell precursor acute lymphoblastic leukaemia
di: Vaibhav Agrawal, et al.
Pubblicazione: (2025)

(Table 1) Nd-isotope ratios of oceanic basalts
di: O'Nions, R K, et al.
Pubblicazione: (1977)

(Table 2) Sr-isotope ratios of oceanic basalts
di: O'Nions, R K, et al.
Pubblicazione: (1977)

(Table 3) Sr and Nd-isotope ratios of oceanic basalts from DSDP Site 37-332
di: O'Nions, R K, et al.
Pubblicazione: (1977)

Nd- and Sr- isotope ratios of oceanic basalts
di: O'Nions, R K, et al.
Pubblicazione: (1977)

Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy
di: Dongchan Kim, et al.
Pubblicazione: (2024)

Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy
di: Harmony Leroy, et al.
Pubblicazione: (2024)

Sweet's syndrome in acute myeloid leukaemia
di: Hsu T. Mon, et al.
Pubblicazione: (2026)

The Mozart effect in chronic myeloid leukaemia
di: Jesper Stentoft
Pubblicazione: (2024)

Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
di: Amber Gibson, et al.
Pubblicazione: (2024)

Venetoclax in the treatment of acute myeloid leukemia: Beyond VIALE‐A
di: Naseema Gangat, et al.
Pubblicazione: (2024)

Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study
di: André Baruchel, et al.
Pubblicazione: (2025)

Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy
di: Takaaki Konuma, et al.
Pubblicazione: (2025)

An old leukaemia in young patients—Genetic characteristics of paediatric chronic myeloid leukaemia
di: Markus Metzler, et al.
Pubblicazione: (2025)

Immunophenotypic clustering in paediatric acute myeloid leukaemia
di: Hui Liu, et al.
Pubblicazione: (2024)